Drug Delivery Devices Market Players:
- Antares Pharma, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Novartis International AG
- Johnson & Johnson
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Otsuka Pharmaceutical Co., Ltd.,
- Abbott Laboratories
- Cipla Limited
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of drug delivery devices is assessed at USD 449.73 billion.
The global drug delivery devices market size was valued at over USD 422.72 billion in 2025 and is expected to expand at a CAGR of around 7.1%, surpassing USD 839.36 billion revenue by 2035.
North America drug delivery devices market will dominate over 42% share by 2035, fueled by increased product launches and rising cancer cases.
Key players in the market include Antares Pharma, Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Novartis International AG, Johnson & Johnson, GlaxoSmithKline plc, Merck & Co., Inc., Otsuka Pharmaceutical Co., Ltd., Abbott Laboratories, Cipla Limited.
